DUBLIN, Jan. 3, 2024
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that
its Chief Executive Officer, Richard
Pops, will provide a corporate overview and update at the
42nd Annual J.P. Morgan Healthcare Conference. The
presentation will take place on Wednesday,
Jan. 10, 2024 at 11:15 a.m.
PST (2:15 p.m.
EST/7:15 p.m. GMT), followed
by a question and answer session. The live webcast may be accessed
under the Investors tab on www.alkermes.com and will be
archived for 14 days.
About Alkermes plc
Alkermes plc is a global
biopharmaceutical company that seeks to develop innovative
medicines in the field of neuroscience. The company has a portfolio
of proprietary commercial products for the treatment of alcohol
dependence, opioid dependence, schizophrenia and
bipolar I disorder, and a pipeline of clinical and preclinical
candidates in development for neurological disorders. Headquartered
in Dublin, Ireland,
Alkermes has a research and development center in
Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025512.html
SOURCE Alkermes plc